INmune Bio is a clinical-stage biotechnology company that develops immunotherapies that reprogram a patient’s innate immune system. It offers INKmune, an NK cell (natural killer cell) to kill cancer; INB03, a protein biologic that changes the tumor microenvironment (TME) improving the response to targeted therapies for cancer; XPro1595, a protein biologic that targets Soluble receptors for tumor necrosis factor (sTNF); etc.